Amneal Pharmaceuticals Gets FDA Approval for Alzheimer's Treatment and Brain Tumor Drug
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
Health Digest on MSN5h
Eating Sourdough Bread Every Day Has An Unexpected Effect On Your Body's Nutrient Absorption
When you eat a certain kind of food every day, it can have an unexpected effect on your body -- and that pandemic favorite, ...
verywellhealth1d
You Need More Than Probiotics for a Healthy Gut. Here's the Combo That Works
Discover why probiotics alone aren’t enough to improve gut health. Experts say fiber is the real game-changer in promoting a ...
The Surprising Food That Can Help Reduce Bloating, According to a Gastroenterologist
High-potassium foods: As mentioned earlier, potassium helps your body excrete excess sodium, reducing water retention and ...
Health and Me on MSN4d
3 Best Diets To Follow If You Have IBS- What to Eat And Avoid
Irritable Bowel Syndrome (IBS) affects 10-15% of Americans. Dietary changes, like increasing fiber or following a low FODMAP diet, help manage symptoms. Avoiding trigger foods and staying hydrated is ...
Bausch Health Companies Inc.: Bausch Health Statement on Selection of XIFAXAN (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for ...
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea ...
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...